Enabling immunotherapies in brain cancer
Joan Seoane
ICREA Professor, Research Program Director, Vall d’Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital. Adjunct Professor at Universitat Autònoma de Barcelona
Theatre room, CiMUS
About
Glioblastoma is the most common brain tumor and remains one of the deadliest cancers. I will present our studies related to inflammation and the tumor microenvironment and their impact on immune evasion and response to immunotherapy. I will show how we are trying to develop novel immunotherapies to treat this dismal disease.
Bio
Joan Seoane is an ICREA Research Professor and Director of Research at the Vall d’Hebron Institute of Oncology. He was trained at the University of Barcelona and completed his postdoctoral work at Memorial Sloan-Kettering Cancer Center. His research focuses on the molecular mechanisms of cancer, especially brain tumors such as glioma. He has received major international recognition, including European Research Council grants and leadership roles in the European Association for Cancer Research. He also founded Mosaic Biomedicals, developing innovative cancer therapies that have advanced to clinical trials..
Hosted by PI Anxo Vidal. Cell cycle and Oncology group, CiMUS
Certificates of attendance will be provided upon request at cimus.xestion [at] usc.es (cimus[dot]xestion[at]usc[dot]es). Please do not forget to enter your name and surname in the printout given during the lecture.